Indraprastha Medical Corporation Limited provides hospital services in India. It offers services primarily in the areas of sugar, genomic medicine, elder care, anesthesiology, bariatric and metabolic surgery, bone marrow transplant, dental and cosmetic clinic, dermatology, dietetics and clinical nutrition, endovascular surgery, endocrinology, ENT, fetal medicine, laparoscopic surgery, gynecology and obstetrics, hyperbaric oxygen therapy, IVF, neonatology, nephrology, ophthalmology, pediatric sciences, urology, and surgery, physiotherapy and rehabilitation, psychiatry and clinical psychology, radiology and radio diagnosis, respiratory, rheumatology, spine surgery, urology and andrology, cardiology, oncology, emergency, gastroenterology, neurology/neurosurgery, orthopedics, robotic surgery, and transplant, as well as laboratory services, internal medicine, preventive health, sleep medicine and clinical care, and transfusion medicine. The company was founded in 1983 and is based in New Delhi, India.
Stock data | 2023 | Change |
---|---|---|
Price | $4.87 | N/A |
Market Cap | $446.20M | N/A |
Shares Outstanding | 91.67M | 0.00% |
Employees | 2.95K | N/A |
Shareholder Equity | 3.79B | 16.60% |
Valuation | 2023 | Change |
---|---|---|
P/E Ratio | 0.52 | N/A |
P/S Ratio | 3.51 | N/A |
P/B Ratio | 0.12 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | 0.0027 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $127.06M | N/A |
Earnings | $10.28M | N/A |
EPS | 9.40 | N/A |
Earnings Yield | 1.93 | N/A |
Gross Margin | 0.5548 | N/A |
Operating Margin | 0.1055 | N/A |
Net income margin | 0.0809 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $66.23M | N/A |
Total Debt | $295.89K | N/A |
Cash on Hand | $15.82M | N/A |
Debt to Equity | 0.0055 | 10.58% |
Cash to Debt | $53.46 | 301.03% |
Current Ratio | $1.72 | 2.21% |